Ikegame Kazuhiro Department
Specialty Division
, Clinical Medicine Seminars
Position
■ Journal
1.
Original article
Allogeneic hematopoietic stem cell transplantation from a 2-HLA-haplotype-mismatched family donor for posttransplant relapse: a prospectiv phaseⅠ/Ⅱ study 2020/06
2.
Original article
Effects of Antifungal Stewardship Using Therapeutic Drug Monitoring in Voriconazole Therapy on the Prevention and Control of Hepatotoxicity and Visual Symptoms: A Multicentre Study Conducted in Japan. 2020/08
3.
Other
Allogeneic hematopoietic stem cell transplantation for adult patients with B-cell acute lymphoblastic leukemia harboring t(1;19)(q23;p13.3); comparison with normal karyotype. 2020/07
4.
Original article
Allogeneic Hematopoietic Cell Transplantation for Adults With Acute Myeloid Leukemia Conducted in Japan During the Past Quarter Century. 2020/06
5.
Introduction
Clinical practice recommendations for the diagnosis and management of human herpesvirus-6B encephalitis after allogeneic hematopoietic stem cell transplantation: the Japan Society for Hematopoietic Cell Transplantation. 2020/06
6.
Original article
Mixed Chimerism and Secondary Graft Failure in Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia. 2020/03
7.
Original article
Antigen-presenting cells constitutively bind tumor antigens in the tumor-bearing state in vivo to construct an effective immunogenic unit. 1991/03
8.
Original article
Evidence for the functional binding in vivo of tumor rejection antigens to antigen-presenting cells in tumor-bearing hosts. 1991/03
9.
Original article
Tumor-bearing mice exhibit a progressive increase in tumor antigen-presenting cell function and a reciprocal decrease in tumor antigen-responsive CD4+ T cell activity. 1992/01
10.
Original article
Tumor-immunotherapy with the use of tumor-antigen-pulsed antigen-presenting cells. 1992/01
11.
Original article
Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3. 1997/08
12.
Original article
A new member of a hepatoma-derived growth factor gene family can translocate to the nucleus. 1999/12
13.
Case report
Pleural effusion during interferon treatment for chronic hepatitis C. 2000/09
14.
Case report
Lethal adenovirus infection in a patient who had undergone nonmyeloablative stem cell transplantation. 2001/07
15.
Other
Combination of tacrolimus, methotrexate, and methylprednisolone prevents acute but not chronic graft-versus-host disease in unrelated bone marrow transplantation. 2002/07
16.
Other
Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers. 2002/07
17.
Other
Antibodies against hepatoma-derived growth factor and mucosal repair in ulcerative colitis. 2002/11
18.
Case report
Successful treatment of refractory T-cell acute lymphoblastic leukemia by unmanipulated stem cell transplantation from an HLA 3-loci mismatched (haploidentical) sibling. 2003/03
19.
Other
The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia. 2003/03
20.
Other
Treatment of severe life-threatening graft-versus-host disease by autologous peripheral blood stem cell transplantation using a nonmyeloablative preconditioning regimen. 2003/03
21.
Case report
Successful treatment of bcr/abl-positive acute mixed lineage leukemia by unmanipulated bone marrow transplantation from an HLA-haploidentical (3-antigen-mismatched) cousin. 2003/06
22.
Other
Overexpression of the Wilms' tumor gene WT1 in primary thyroid cancer. 2003/07
23.
Other
Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis. 2003/07
24.
Original article
Successful engraftment of HLA-haploidentical related transplants using nonmyeloablative conditioning with fludarabine, busulfan and anti-T-lymphocyte globulin. 2003/10
25.
Other
Monitoring minimal residual disease in leukemia using real-time quantitative polymerase chain reaction for Wilms tumor gene (WT1). 2003/11
26.
Original article
Absence of mutations in the Wilms' tumor gene wt1 in de novo non-small cell lung cancers. 2004/01
27.
Other
Absence of mutations in the Wilms' tumor gene WT1 in primary breast cancer. 2004/02
28.
Other
Allogeneic bone marrow transplantation with non-T-cell-depleted marrow from two HLA-antigen-mismatched related donors. 2004/03
29.
Original article
Identification of a gene element essential for leukemia-specific expression of transgenes. 2004/03
30.
Other
Successful treatment of life-threatening human herpesvirus-6 encephalitis with donor lymphocyte infusion in a patient who had undergone human leukocyte antigen-haploidentical nonmyeloablative stem cell transplantation. 2004/03
31.
Original article
Preferential expression of the vasoactive intestinal peptide (VIP) receptor VPAC1 in human cord blood-derived CD34+CD38- cells: possible role of VIP as a growth-promoting factor for hematopoietic stem/progenitor cells. 2004/05
32.
Other
Impact of cytogenetics on outcome of stem cell transplantation for acute myeloid leukemia in first remission: a large-scale retrospective analysis of data from the Japan Society for Hematopoietic Cell Transplantation. 2004/06
33.
Other
Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma. 2004/07
34.
Other
WT1 peptide vaccination combined with BCG-CWS is more efficient for tumor eradication than WT1 peptide vaccination alone. 2004/07
35.
Other
Powerful graft-versus-leukemia effects exerted by HLA-haploidentical grafts engrafted with a reduced-intensity regimen for relapse following myeloablative HLA-matched transplantation. 2004/08
36.
Other
Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression. 2004/09
37.
Other
WT1 gene transcript assay for relapse in acute leukemia after transplantation. 2004/09
38.
Other
Successful treatment of tacrolimus (FK506)-related leukoencephalopathy with cerebral hemorrhage in a patient who underwent nonmyeloablative stem cell transplantation. 2004/10
39.
Other
Unmanipulated reduced-intensity stem cell transplantation from a haploidentical donor mismatched at 3 HLA antigens to a patient with leukemic transformation of myelodysplastic syndrome: successful second transplantation after graft rejection. 2004/12
40.
Original article
Th1-biased humoral immune responses against Wilms tumor gene WT1 product in the patients with hematopoietic malignancies. 2005/02
41.
Original article
HLA-haploidentical nonmyeloablative stem cell transplantation: induction to tolerance without passing through mixed chimaerism. 2005/04
42.
Other
A case of immune recovery vitritis induced by donor leukocyte infusion for the treatment of cytomegalovirus retinitis. 2005/10
43.
Case report
Idiopathic thrombocytopenic purpura after influenza vaccination in a bone marrow transplantation recipient. 2006/08
Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis. 2008/01
46.
Other
Unrelated umbilical cord blood transplantation using a TBI/FLAG conditioning regimen for adults with hematologic malignancies. 2008/08
47.
Other
Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor. 2008/09
48.
Other
Hepatosplenic alphabeta T cell lymphoma. 2010/04
49.
Other
Separation of antileukemic effects from graft-versus-host disease in MHC-haploidentical murine bone marrow transplantation: participation of host immune cells. 2010/04
50.
Other
Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor. 2010/09
51.
Other
Dasatinib is effective against optic nerve infiltration of Philadelphia chromosome-positive acute lymphoblastic leukemia. 2010/10
52.
Other
Usefulness of glycated albumin as an indicator of glycemic control status in patients with hemolytic anemia. 2011/01
53.
Other
Successful treatment with nilotinib after imatinib failure in a CML patient with a four-way Ph chromosome translocation and point mutations in BCR/ABL gene. 2011/02
54.
Other
Direct antiglobulin test-negative autoimmune hemolytic anemia associated with HLA-haploidentical stem cell transplantation. 2011/04
55.
Other
Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan. 2011/04
56.
Other
Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation. 2011/08
57.
Other
Strategy for bone marrow transplantation in eculizumab-treated paroxysmal nocturnal hemoglobinuria. 2011/10
58.
Other
Dasatinib-induced rapid regression and complete molecular remission of multiple subcutaneous tumours presenting as relapsed chronic myeloid leukaemia after cord blood transplantation. 2011/12
59.
Original article
Salvage haploidentical transplantation for graft failure using reduced-intensity conditioning 2012/03
60.
Other
Impaired physiological function and health-related QOL in patients before hematopoietic stem-cell transplantation. 2012/04
61.
Other
Intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning treatment: a phase I study. 2012/04
62.
Original article
Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT 2012/04
63.
Original article
Incidence of extramedullary relapse after haploidentical SCT for advanced AML/myelodysplastic syndrome 2012/05
64.
Other
Feasibility of unmanipulated haploidentical stem cell transplantation using standard GVHD prophylaxis for HLA-homozygous patients. 2012/07
65.
Other
Incidence and treatment strategy for disseminated adenovirus disease after haploidentical stem cell transplantation. 2012/08
66.
Original article
Donor-derived HLA antibody production in patients undergoing SCT from HLA antibody-positive donors 2012/10
67.
Other
Haploidentical hematopoietic stem cell transplantation for lymphoma with monosomy of chromosome 6 (loss of heterozygosity in the HLA region)--who should be a donor? 2012/12
68.
Other
Impact of the mobilization regimen and the harvesting technique on the granulocyte yield in healthy donors for granulocyte transfusion therapy. 2012/12
69.
Other
Prevalence of sarcopenia and relevance of body composition, physiological function, fatigue, and health-related quality of life in patients before allogeneic hematopoietic stem cell transplantation. 2012/12
70.
Original article
Allogeneic hematopoietic stem cell transplantation for intermediate cytogenetic risk AML in first CR 2013/01
71.
Original article
Gender differences in health-related quality of life, physical function and psychological status among patients in the early phase following allogeneic haematopoietic stem cell transplantation. 2013/05
72.
Original article
Safety and feasibility of physical therapy in cytopenic patients during allogeneic haematopoietic stem cell transplantation. 2013/05
73.
Original article
Frequency of CD4(+)FOXP3(+) regulatory T-cells at early stages after HLA-mismatched allogeneic hematopoietic SCT predicts the incidence of acute GVHD. 2013/06
74.
Original article
Impact of hepatitis C virus infection on clinical outcome in recipients after allogeneic hematopoietic cell transplantation. 2013/06
75.
Original article
Impact of a donor source on adult Philadelphia chromosome-negative acute lymphoblastic leukemia: a retrospective analysis from the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation. 2013/07
76.
Original article
Relationship between corticosteroid dose and declines in physical function among allogeneic hematopoietic stem cell transplantation patients. 2013/08
77.
Original article
Irreversible neurological defects in the lower extremities after haploidentical stem cell transplantation: possible association with nelarabine. 2013/10
78.
Original article
Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation. 2013/11
79.
Original article
Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease 2014/02
80.
Original article
Soluble interleukin-2 receptor level on day 7 as a predictor of graft-versus-host disease after HLA-haploidentical stem cell transplantation using reduced-intensity conditioning. 2014/04
81.
Original article
Risk analysis of falls in patients undergoing allogeneic hematopoietic stem cell transplantation. 2014/08
82.
Original article
Impact of HLA allele mismatch on the clinical outcome in serologically matched related hematopoietic SCT 2014/09
83.
Original article
Prediction of Skin Trouble in Patients Undergoing Allogeneic Hematopietic Stem Cell transplantation Using Generalized Additive Model. 2015/04
84.
Original article
Pharmacokinetics of 8 mg/kg anti-human T-lymphocyte rabbit immunoglobulin conditioning for hematopoietic stem cell transplantation in Japanese patients. 2015/05
85.
Other
A single high-resolution HLA mismatch has a similar adverse impact on the outcome of related hematopoietic stem cell transplantation as a single low-resolution HLA mismatch. 2015/07
86.
Original article
Unmanipulated HaploidenticalReduced-Intensity Stem Cell Transplantation Using Fludarabine, Busulfan, Low-Dose Antithymocyte Globulin, and Steroids for Patients in Non-Complete Remission or at High Risk of Relapse: A Prospective Multicenter Phase I/II Study in Japan. 2015/08
87.
Original article
Balance function in patients who had undergone allogeneic hematopoietic stem cell transplantation. 2015/09
88.
Original article
Early detection of cytomegalovirus-specific cytotoxic T lymphocytes against cytomegalovirus antigenemia in human leukocyte antigen haploidentical hematopoietic stem cell transplantation. 2015/10
89.
Other
Early-phase differences in health-related quality of life, psychological status, and physical function between human leucocyte antigen-haploidentical and other allogeneic haematopoietic stem cell transplantation recipients. 2015/10
90.
Original article
Host Foxp3+CD4+ Regulatory T Cells Act as a Negative regulator of dendritic cells in the peritransplantation period. Journal of Immunology. 2016/01
91.
Case report
Allogeneic stem cell transplantation for X-linked agammaglobulinemia using reduced intensity conditioning as a model of the reconstitution of humoral immunity. 2016/02
92.
Original article
Haploidentical and Matched Sibling Donor Hematopoietic Cell Transplantation for Patients with HLA-Homozygous Haplotypes. 2016/11
93.
Original article
Low-dose thymoglobulin as second-line treatment for steroid-resistant acute GvHD: an analysis of the JSHC 2017/02
94.
Case report
Effective desensitization of donor-specific HLA antibodies using platelet transfusion bearing targeted HLA in a case of HLA-mismatched allogeneic stem cell transplantation 2017/05
Relationship of physical activity with physical function and health-related quality of life in patients having undergone allogeneic haematopoietic stem-cell transplantation 2017/07
97.
Original article
Impact of the presence of HLA 1-locus mismatch and the use of low-dose antithymocyte globulin in unrelated bone marrow transplantation 2017/10
98.
Original article
Fatigue, Muscle Oxygen Consumption and Blood Flow to the Skeletal Muscle After Allogeneic Hematopoietic Stem Cell Transplantation. 2018
99.
Other
Hemoglobin Dynamics in the Skeletal Muscle of Patients with Malignant Hematopoietic Disease. 2018/01
100.
Original article
A prospective multicenter phase II study of intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning. 2018/04
101.
Original article
Impact of pretransplant leukemic blast% in bone marrow and peripheral blood on transplantation outcomes of patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation in non-CR. 2018/04
102.
Original article
Impaired skeletal muscle oxygenation following allogeneic hematopoietic stem cell transplantation is associate with exercise capacity 2018/07
103.
Original article
Changes in Borg scale for resistance training and test of exercise tolerance in patients undergoing allogeneic hematopoietic stem cell transplantation. 2018/09
104.
Original article
Hemoglobin Dynamics in the Skeletal Muscle of Patients with Malignant Hematopoietic Disease. 2018/09
105.
Case report
Effect of low platelet HLA-C expression on donor-specific antibody depletion following platelet transfusion from a corresponding HLA donor. 2019/03
106.
Original article
HLA discrepancy between graft and host rather than that graft and first donor impact the second transplant outcome. 2019/05
107.
Other
HLA discrepancy between graft and host rather than that graft and first donor impact the second transplant outcome. 2019/05
108.
Original article
Low incidence of HHV-6 reactivation in haploidentical hematopoietic stem cell transplantation with corticosteroid as graft-vs-host disease prophylaxis compared with cord blood transplantation. 2019/06
109.
Original article
Risk Factors and Predictive Scoring System For Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation. 2019/07
110.
Other
Risk Factors and Predictive Scoring System For Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation. 2019/07
111.
Original article
Safety and efficacy of amnion-derived mesenchymal stem cells (AM01) in patients with steroid-refractory acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: a study protocol for a phase I/II Japanese trial. 2019/07
112.
Original article
Comparison of Outcomes of Allogeneic Transplantation for Primary Myelofibrosis among Hematopoietic Stem Cell Source Groups. 2019/08
113.
Original article
Comparison of Outcomes of Allogeneic Transplantation for Primary Myelofibrosis among Hematopoietic Stem Cell Source Groups. 2019/08
114.
Original article
Allogeneic haematopoietic stem cell transplantation for primary mediastinal large B-cell lymphoma patients relapsing after high dose chemotherapy with autologous stem cell transplantation: data from the Japan Society for Haematopoietic Cell Transplantation registry. 2019/09
115.
Original article
Hematopoietic stem-cell transplantation in children with refractory acute myeloid leukemia. 2019/09
116.
Original article
Risk Stratification and Prognosticators of Acute Myeloid Leukemia with Myelodysplasia-Related Changes in Patients Undergoing Allogeneic Stem Cell Transplantation: A Retrospective Study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation. 2019/09
117.
Case report
Effect of low platelet HLA-C expression on donor-specific antibody depletion following platelet transfusion from a corresponding HLA donor. 2019/10
118.
Original article
Using a machine learning algorithm to predict acute graft-versus-host disease following allogeneic transplantation. 2019/11
119.
Original article
Impact of High-Frequency HLA Haplotypes on Clinical Cytomegalovirus Reactivation in Allogeneic Hematopoietic Stem Cell Transplantation. 2019/12
120.
Original article
Relationship Between Exercise Capacity and Muscle O2 2020
121.
Other
Better disease control before allogeneic stem cell transplantation is crucial to improve the outcomes of transplantation for acute myeloid leukemia patients with extramedullary disease. 2020/01
122.
Original article
Hematopoietic Stem Cell Transplantation in Solid Organ Recipients with Emphasis on Transplant Complications: A Nationwide Retrospective Survey on Behalf of the Japan Society for Hematopoietic Stem Cell Transplantation Transplant Complications Working Grou 2020/01
123.
Original article
Relationship Between Exercise Capacity and Muscle O2Hb Saturation in Patients Before Hematopoietic Stem-Cell Transplantation. 2020/01
124.
Original article
Relationship Between Muscle Oxygen Saturation and Exercise Load in Patients with Malignant Hematopoietic Disease 2020/01
125.
Original article
Could the minimum number of haematopoietic stem cells to obtain engraftment exist in unrelated, single cord blood transplantation? 2020/02
126.
Original article
A consideration for efficient unrelated hematopoietic stem cell source acquisition-from an experience of Japan. 2020/03
127.
Original article
Heterogeneous Impact of Cytomegalovirus Reactivation on Nonrelapse Mortality in Hematopoietic Stem Cell Transplantation. 2020/03
128.
Original article
Tacrolimus Concentration after Letermovir Initiation in Hematopoietic Stem Cell Transplantation Recipients Receiving Voriconazole: A Retrospective, Observational Study. 2020/03
129.
Original article
Relationship Between Exercise Capacity and Muscle O(2)Hb Saturation in Patients Before Hematopoietic Stem-Cell Transplantation 2020/06
130.
Original article
Allogeneic hematopoietic cell transplantation efficacy in patients with Philadelphia chromosome-positive acute myeloid leukemia in complete remission 2020/07
131.
Case report
Toxoplasmic Encephalitis Followed by Primary EBV-Associated Post-Transplant Lymphoproliferative Disorder of the Central Nervous System in a Patient Undergoing Allogeneic Hematopoietic Stem Cell Transplant: A Case Report 2020/08
132.
Other
Comparison of the outcomes after haploidentical and cord blood salvage transplantations for graft failure following allogeneic hematopoietic stem cell transplantation. 2020/09
133.
Original article
Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with paroxysmal nocturnal hemoglobinuria 2020/09
134.
Original article
Use of unapproved or off-label drugs in Japan for the treatment of graft-versus-host disease and post-transplant viral infection. 2020/12
135.
Original article
Muscle oxygen extraction and lung function are related to exercise tolerance after allogeneic hematopoietic stem cell transplantation 2021/03
136.
Original article
Muscle oxygen extraction and lung function are related to exercise tolerance after allogeneic hematopoietic stem cell transplantation 2021/08
137.
Original article
Severe acute graft-versus-host disease increases the incidence of blood stream infection and mortality after allogeneic hematopoietic cell transplantation: Japanese transplant registry study. 2021/09
138.
Original article
Syngeneic hematopoietic stem cell transplantation for acute myeloid leukemia: a propensity score-matched analysis. 2021/09
139.
Original article
Impact of the use of hydroxyethyl starch in granulocyte apheresis using Spectra Optia 2021/10
140.
Original article
Cytomegalovirus reactivation is associated with an increased risk of late-onset invasive aspergillosis independently of grade II-IV acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: JSTCT Transplant Complications Working Group. 2021/12
141.
Original article
Impact of HLA disparity on the risk of overall mortality in patients with grade II-IV acute GVHD on behalf of the HLA Working Group of Japan Society for Hematopoietic Cell Transplantation. 2021/12
142.
Original article
Outcomes of third allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute leukemia after a second transplantation. 2022/01
143.
Original article
Deletion of Y-chromosome before allogeneic hematopoietic stem cell transplantation in male recipients with female donors. 2022/02
144.
Original article
Donor lymphocyte infusion after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia. 2022/03
145.
Original article
HLA 1-3 antigen-mismatched related peripheral blood stem cells transplantation using low-dose antithymocyte globulin versus unrelated cord blood transplantation. 2022/03
146.
Original article
Risk and Predictive Factors for Candidemia After Allogeneic Hematopoietic Cell Transplantation: JSTCT Transplant Complications Working Group. 2022/04
147.
Original article
Risk factors and prognosis of non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation. 2022/04
148.
Original article
Balance Function after Balance Exercise Assist Robot Therapy in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Pilot Study 2023/02
Higher corticosteroid dose declines physical function, but does not affect psychosocial function among allogeneic hematopoietic stem-cell transplantation patients (Poster presentation,General Lecture) 2013/06
2.
Effect of physical therapy on physical function and QOL in patients undergoing allogeneic hematopoietic transplantation (Poster presentation,General Lecture) 2013/09
3.
HLA haploidentical transplantation and further. (Oral presentation,Special/Invited Lecture) 2013/11/03
4.
haploidentical transplantation and further (Oral presentation,General Lecture) 2014/04
5.
Early-phase differences in health-related QOL, psychological status, and physical function between HLA-haploidentical and other allo-HSCT recipients (Oral presentation,General Lecture) 2014/06
6.
Graft-versus-GVHD, a second transplantation from another donor for the resucue from refractory acute GVHD. (Oral presentation,General Lecture) 2014/09
7.
Morning Discussion (Meet the Expert) (Oral presentation,Symposium/Workshop/Panel Discussion) 2014/10
8.
Prediction of Skin Trouble in Patients Undergoing Allogeneic Hematopietic Stem Cell transplantation Using Generalized Additive Model (Oral presentation,General Lecture) 2015/02
The Impact of HLA Mismatch Only in the Host-Versus-Graft Direction on the Outcome of Related Hematopoietic Stem Cell Transplantation for Patients with HLA-Homozygous Haplotype: A Retrospective Analysis of The JSHCT HLA Working Group Study (Oral presentation,General Lecture) 2015/02
11.
“Low Incidence of Human Herpesvirus 6 Reactivation in Unmanipulated HLA-Haploidentical Related Stem Cell Transplantation with Corticosteroid As Graft-Versus-Host Disease Prophylaxis. (Oral presentation,General Lecture) 2015/02
12.
Hematopoietic stem cell transplantation using a related donor not sharing HLA-haplotype (Oral presentation,General Lecture) 2015/03/06
13.
Maturation of dendritic cells restrained by host Foxp3+CD4+regulatory T cells: the critical role in the induction of graft-veusus-host reaction after experimental BMT. (Oral presentation,General Lecture) 2015/03/06
14.
The balance function in patients undergoing allogeneic hematopoietic transplantation. (Poster presentation,General Lecture) 2015/03/06
15.
The haplo-mini-SCT for the secondary central nervous system (CNS) lymphoma (Poster presentation,General Lecture) 2015/03/06
16.
The impact of HLA-mismatch only in the HVG direction on the outcome of related hematopoietic stem cell transplantation for patients with HLA-homozygous haplotypes: a retrospective analysis of JSHCT HLA working group. (Oral presentation,General Lecture) 2015/03/06
17.
Based on haplo, beyond haplo. (Oral presentation,Symposium/Workshop/Panel Discussion) 2015/03/07
18.
Risk analysis of falls and skin lesions in patients undergoing allogeneic hematopoietic stem cell transplantation. (Oral presentation,General Lecture) 2016/02
19.
Unmanipulated HLA haploidentical allogeneic stem cell transplantation from family members using Steroid-containing GVHD prophylaxis for refractory hematological malignancies. (Oral presentation,General Lecture) 2016/02
20.
A case report with MDS who underwent haploindentical transplantation after umbilical cord blood transplantation with Mixed cheimerism state over a long period of time. (Poster presentation,General Lecture) 2016/03/04
21.
Allogeneic Stem Cell Transplantation for X-linked agammaglobulinemia as a model of the reconstitution of humoral immunity (Oral presentation,General Lecture) 2016/03/04
22.
clinical outcomes of HLA haploidentical hematopoietic stem cell transplantation in patients with Philadelphia Chromosome positive Acute Lymphoblastic Leukemia in our institute (Oral presentation,General Lecture) 2016/03/04
23.
Graft-versus-host disease-free,relapse-free,survival(GRFS)of patients with hematological malignancy according to donor type: JSHCT Working Group study. (Oral presentation,General Lecture) 2016/03/04
24.
Hyogo haplo should be best for AML PIF in young patients with spared organ function and ADL (Oral presentation,Symposium/Workshop/Panel Discussion) 2016/03/05
25.
Unmanipulated haploidentical RIST using Fludarabine, Busulfan, low-dose ATG and steroid for patients in non-CR or at high risk of relapse: a prospective multicenter phase III study in Japan.” (Oral presentation,General Lecture) 2016/05
26.
A case of cerebral toxoplasmosis and EBV-associated post-transplant lymphoproliferative disorder of the central nervous system following allogeneic hematopoietic stem cell transplantation (Poster presentation,General Lecture) 2017/03/02
27.
Effective Desensitization of Donor-specific HLA Antibodies Using Platelet Transfusion Bearing Targeted HLA in a Case of HLA-mismatched Allogeneic Stem Cell Transplantation (Poster presentation,General Lecture) 2017/03/02
28.
One example of acute myeloid leukemia for severe hepatic dysfunction due to acute GVHD who underwent living donor liver transplantation from hematopoietic stem cell donor (Poster presentation,General Lecture) 2017/03/02
29.
The investigation of resistance exercise load and perceived exertion in patients undergoing allogeneic hematopoietic transplantation (Poster presentation,General Lecture) 2017/03/02
30.
Physilogical characteristics of the 6-minute walk test in patients undergoing allogeneic hematopoietic transplantation (Poster presentation,General Lecture) 2017/03/03
31.
Team approach to allo-hematopoietic stem cell transplantation:From the physical therapist's view (Oral presentation,Special/Invited Lecture) 2017/03/03
32.
Association beteween plasma concentration of antithymocyte globulin(ATG) and acute graft versus host disease(GVHD) granding on haploidentical hematopoietic stem cell transplantation (Oral presentation,General Lecture) 2017/03/04
33.
Relationship between muscle endurance and muscle oxidative consumption in patients who received allogeneic hematopoietic stem cell transplantation (Poster presentation,General Lecture) 2017/06/27
34.
Effectiveness of balance exercise assist robot (BEAR) for allogeneic hematopoietic stem cell transplantation patients: a preliminary study (Poster presentation,General Lecture) 2017/06/28
35.
Muscle oxygen consumption and blood flow to the skeletal muscle in patients with malignant hematopoietic disease (Poster presentation,General Lecture) 2017/08/19
36.
Muscle oxidative extraction in patients with hematological malignancy (Poster presentation,General Lecture) 2018/02/01
37.
Prognostic value of WT1 on HLA-haploidentical RIST for non-remission leukemia (Oral presentation,General Lecture) 2018/02/02
38.
Relationship of 6-minute walk test,muscle strength,and physiological response in HSCT patients (Poster presentation,General Lecture) 2018/02/02
39.
Relationship of resistance exercise and perceived exertion in HSCT patients (Poster presentation,General Lecture) 2018/02/02
40.
Prediction of hemorrhagic cystitis using antibody to ADV type11 and prophylastic value of cidofovir (Oral presentation,General Lecture) 2018/02/03
41.
Muscle oxygen saturation during muscle endurance test in patients with malignant hematopoietic disease (Poster presentation,General Lecture) 2018/07/03
42.
Relationship between exercise capacity and muscle O2Hb saturation in patients before hematopoietic stem-cell transplantation (Oral presentation,General Lecture) 2018/07/04
43.
The effect of balance exercise assist robot (BEAR) to patient after allogenetic hematopoietic stem cell transplantation (allo-HSCT); preliminally study. (Poster presentation,General Lecture) 2018/07/08
44.
Changes in heart rate and Borg scale after the exercise-tolerance test in allogeneic hematopoietic stem cell transplantation patients (Poster presentation,General Lecture) 2018/07/11
45.
Detailed bone marrow plasma cell phenotyping in the patients with suspected plasma cell disorders. (Oral presentation,General Lecture) 2018/10/14
46.
Dose CMV reactivation reduce AML relapse risk in HCM-style HLA-haploidentical RIST? (Oral presentation,General Lecture) 2019/03/08
47.
Granulocyte collections using Spectra Optia with or without the use of hydroxyethy1 starch (Oral presentation,General Lecture) 2019/03/08
48.
HLA haploidentical transpantation in AYAs (Oral presentation,General Lecture) 2019/03/08
49.
HLA-mismatched stem cell transplantation from family members for super-high risk disease (Oral presentation,Symposium/Workshop/Panel Discussion) 2019/03/08
50.
Isohemagglotinin production after minor ABO-incompatible peripheral blood stem cell transplantation (Oral presentation,General Lecture) 2019/03/08
51.
Steroid-resistant,homeostatically-proliferationg donor T cells in BM suppresses GVHD preserving GVL (Oral presentation,General Lecture) 2019/03/08
52.
Usefulness of measuring hematology analyzer-based HPC in peripheral blood stem cell harvest (Poster presentation,General Lecture) 2019/03/08
53.
Retrospective analysis of allogeneic stem cell transplantation for PNH (Oral presentation,General Lecture) 2019/03/09
54.
Secondary malignancies after hematopoietic stem cell transplantation in Hyogo college of medicine (Oral presentation,General Lecture) 2019/03/09
55.
Verification of the availability of allogeneic stem cell source based on the transplant achievement (Oral presentation,General Lecture) 2019/03/09
56.
Impaired muscle oxygen consumption during exercise after allo-HSCT is related to lower muscle mass at the time of engraftment in a sterile isolation room (Poster presentation,General Lecture) 2019/06/11
57.
The effect of Balance Exercise Assist Robot (BEAR) is related to balance function before intervention in patients after allogeneic hematopoetic stem cell transplantation. (Poster presentation,General Lecture) 2019/06/11
58.
The Optimal Treatment Strategy for Adult Patients with Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia in First Remission in the Era of High-intensity Chemotherapy. (Oral presentation,General Lecture) 2019/12
59.
Phase II trial of fecal microbiota transplantation for steroid-resistant gastrointestinal acute GVHD (Oral presentation,General Lecture) 2020/03
Effect of allogeneic SCT in AML patients with or without extramedullary disease (Oral presentation,General Lecture) 2020/03/07
66.
Effect of letermovir on blood concentration of voriconazole (Poster presentation,General Lecture) 2020/03/07
67.
Haploidentical SCT with steroid-containing GVHD prophylaxis for AML in non-CR:comarison with matched sibling SCT from the TRUMP data (Oral presentation,General Lecture) 2020/03/07
68.
Unmanipulated haploientical stem cell transplantation using low-dose ATG and steroid for high-risk disease (Oral presentation,Symposium/Workshop/Panel Discussion) 2020/03/07
69.
Allogeneic hematopoietic stem cell transplantation for adult patients with B-cell acute lymphoblastic leukaemia with high hyperdiploidy: A retrospective nationwide study of the Japan Society for Hematopoietic Cell Transplantation (Oral presentation,General Lecture) 2020/06
70.
Decision making in AYA patients with hematological malignancy underwent HLA mismatch transplants. (Web announcement,General Lecture) 2021/03
71.
Survival-time analysis using recurrent neural networks in hematopoietic stem cell transplantation (Web announcement,General Lecture) 2021/03
72.
Tisagenlecleucel for Diffuse Large B-cell Lymphoma:A Single Center Experience (Web announcement,General Lecture) 2021/03
73.
Two cases of incidental plasma cell neoplasm: diagnostic roles of EMA and CD79a immunohistochemistry (Poster presentation) 2021/09/23